Lakefront Biotherapeutics NV
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $807.9M |
| FY2022 | — | — | $97.3M |
| FY2023 | — | — | $34.5M |
| FY2024 | — | — | $40.3M |
| FY2025 | — | — | $40.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $807.9M |
| FY2022 | — | — | $97.3M |
| FY2023 | — | — | $34.5M |
| FY2024 | — | — | $40.3M |
| FY2025 | — | — | $40.0M |